SCHEMBL4190401

SCHEMBL4190401

CCCCCCCCCCc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.77
TSHR P16473 1/20 0.56
ALDH1A1 P00352 2/20 0.54
ESR1 P03372 2/20 0.53
ADRA2A P08913 2/20 0.53
ADORA3 P0DMS8 2/20 0.53
TACR2 P21452 2/20 0.53
SLC6A2 P23975 2/20 0.53
SLC6A4 P31645 2/20 0.53
SLC6A3 Q01959 2/20 0.53
KDM4E B2RXH2 1/20 0.53
LMNA P02545 1/20 0.53
SHBG P04278 1/20 0.53
TP53 P04637 1/20 0.53
CYP3A4 P08684 1/20 0.53
HSPD1 P10809 1/20 0.53
ADRB3 P13945 1/20 0.53
HTR2C P28335 1/20 0.53
HSPE1 P61604 1/20 0.53
HIF1A Q16665 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11075250 1.00 KCNH2 (0.77) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL6678908 1.00 KCNH2 (0.77) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL1881781 1.00 KCNH2 (0.77) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL25171490 1.00 KCNH2 (0.77) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL4310058 1.00 KCNH2 (0.77) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL25174460 1.00 KCNH2 (0.77) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL8743949 1.00 KCNH2 (0.77) KCNH2TSHRALDH1A1ESR1ADRA2A
Ammonia Solution, Strong SCHEMBL16497027 0.98 KCNH2 (0.75) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL680595 0.98 KCNH2 (0.74) KCNH2TSHRALDH1A1ESR1ADRA2A
SCHEMBL1513188 0.95 KCNH2 (0.71) KCNH2TSHRALDH1A1ESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088484-A1 NITRIC OXIDE (NO)-RELEASING POLYMERS AND COMPOUNDS AND USES THEREOF CENTRAL MICHIGAN UNIVERSITY 2009-04-02 US disclosed
US-5618980-A DEHYDROGENATING N-CYCLOHEXYLIDENEAMINO COMPOUND IN PRESENCE OF HYDROGEN TRANSFER CATALYST AND HYDROGEN ACCEPTOR AND ALKALI OR ALKALINE EARTH METAL COMPOUND COCATALYST MITSUI TOATSU CHEMICALS, INC. (JP) 1997-04-08 US disclosed
EP-0588060-B1 Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS (JP) 1997-04-02 EP disclosed
EP-0753505-A2 Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS, Inc. (JP) 1997-01-15 EP disclosed
US-5536878-A HYDROGEN ACCEPTOR MITSUI TOATSU CHEMICALS, INC. (JP) 1996-07-16 US disclosed
US-5382690-A Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-01-17 US disclosed
EP-0588060-A2 Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS, Inc. (JP) 1994-03-23 EP disclosed
EP-0103990-A1 Process for making diarylamines UNIROYAL, INC. (US) 1984-03-28 EP disclosed
US-4431841-A REACTING PRIMARY AROMATIC AMINES AND ALICYCLIC KETONES USING AN ACID PROMOTER AND A PLATINUM CATALYST UNIROYAL, INC. (US) 1984-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088484-A1 NITRIC OXIDE (NO)-RELEASING POLYMERS AND COMPOUNDS AND USES THEREOF NOS2, NOS3, NOS1 KCNH2 3018/4885TSHR 2221/4885ALDH1A1 726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.